Refractory Multiple Myeloma: 1559 Clinical Trials, Page 147 of 156

Hide Studies Not Open or Pending

1469

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Acute Mixed-Phenotype Leukemia; Cancer; Refractory; Progression; Diffuse Large B Cell Lymphoma; Multiple Myeloma; Lymphoma; Lymphoma, Non-Hodgkin; Myeloma, Plasma-Cell; Myelomatosis; Plasma Cell Myeloma; Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:March 5, 2024Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.